论文部分内容阅读
目的 探讨比索洛尔对有冠心病高危因素的胸部肿瘤患者围手术期心律失常的影响.方法 选取2014G8-2015G8期间在我院收治的56例有冠心病高危因素的胸部肿瘤患者,将其随机分为实验组和对照组,每组各28例,实验组患者于术前1周至术后2周每天使用比索洛尔,对照组不使用比索洛尔,观察比较两组患者围手术期心律失常发生情况及心率.结果 实验组患者围手术期心律失常发生率为107%,明显低于对照组的393%;围手术期心率为(621±63)次/min,明显低于对照组,P<005,差异具有统计学意义.结论 有冠心病高危因素的胸部肿瘤患者应用比索洛尔可有效减少围手术期心律失常的发生.
Objective To investigate the effect of bisoprolol on perioperative arrhythmia in patients with chest cancer who are at risk of coronary heart disease.Methods Fifty-six patients with thoracic tumor who were at risk of coronary heart disease were enrolled in our hospital from 2014 to August 2015, For the experimental group and control group, 28 cases in each group, the experimental group of patients in the preoperative 1 week to 2 weeks after the use of bisoprolol every day, the control group did not use bisoprolol, observed and compared the two groups of patients with perioperative arrhythmia Results The incidence of perioperative arrhythmia in the experimental group was 107%, which was significantly lower than that in the control group (393%). The perioperative heart rate was (621 ± 63) / min, significantly lower than that in the control group (P < 005, the difference was statistically significant.Conclusion The application of bisoprolol in patients with thoracic tumors with high risk of coronary heart disease can effectively reduce perioperative arrhythmia.